Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.

International journal of oncology

Volumn 15, Issue 3, 1999, Pages 535-540

  Lucci, A ^a   Giuliano, A E ^a   Han, T Y ^a   Dinur, T ^a   Liu, Y Y ^a   Senchenkov, A ^a   Cabot, M C ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CERAMIDE; GESTAGEN; HORMONE ANTAGONIST; MIFEPRISTONE;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG RESISTANCE; DRUG SCREENING; GENETICS; HUMAN; MULTIDRUG RESISTANCE; PHENOTYPE;

CERAMIDES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ESTROGEN ANTAGONISTS; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; PHENOTYPE; PROGESTINS; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0033192445     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.15.3.535     Document Type: Article

References (0)